Skip to main navigation
Skip to search
Skip to main content
HSC Home
Home
Research units
Profiles
Publications
Sponsored Projects
Core Facilities
Search by expertise, name or affiliation
Three months of rifapentine and isoniazid for latent tuberculosis infection
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Three months of rifapentine and isoniazid for latent tuberculosis infection'. Together they form a unique fingerprint.
rifapentine
Medicine & Life Sciences
100%
Latent Tuberculosis
Medicine & Life Sciences
77%
Isoniazid
Medicine & Life Sciences
67%
Tuberculosis
Medicine & Life Sciences
32%
Group Psychotherapy
Medicine & Life Sciences
27%
Equivalence Trials
Medicine & Life Sciences
8%
Intention to Treat Analysis
Medicine & Life Sciences
7%
Centers for Disease Control and Prevention (U.S.)
Medicine & Life Sciences
6%
Cite this